A new experimental vaccine could offer protection not only against many variants of SARS-CoV-2, but also other sarbecoviruses that could spill over from animals to humans.

Enhances B Cell Responses in Type 2 Inflammation Through IL-17RB Receptor,” published in the January 2025 issue of Allergy ...

Antibodies against B cells Rituximab is a depleting antibody ... Tocilizumab is a monoclonal antibody directed against the IL-6 receptor that has established benefit in RA both with regards ...